药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ranibizumab
Mebeverine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pitavastatin is combined with Mebeverine.
Ranibizumab
Tianeptine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pitavastatin is combined with Tianeptine.
Ranibizumab
Mevastatin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mevastatin is combined with Pitavastatin.
Ranibizumab
Belantamab mafodotin
Pitavastatin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Ranibizumab
Glycyrrhizic acid
Pitavastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.
Ranibizumab
Dihydroergocristine
Pitavastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.
Ranibizumab
Pilsicainide
Pitavastatin may decrease the excretion rate of Pilsicainide which could result in a higher serum level.
Ranibizumab
Indocyanine green acid form
Pitavastatin may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level.
Ranibizumab
Remdesivir
The excretion of Remdesivir can be decreased when combined with Pitavastatin.
Ranibizumab
Idelalisib
The excretion of Pitavastatin can be decreased when combined with Idelalisib.
Ranibizumab
Bempedoic acid
The excretion of Pitavastatin can be decreased when combined with Bempedoic acid.
Ranibizumab
Grazoprevir
The excretion of Grazoprevir can be decreased when combined with Pitavastatin.
Ranibizumab
Tenofovir alafenamide
The excretion of Tenofovir alafenamide can be decreased when combined with Pitavastatin.
Ranibizumab
Valspodar
The excretion of Pitavastatin can be decreased when combined with Valspodar.
Ranibizumab
Elexacaftor
The excretion of Pitavastatin can be decreased when combined with Elexacaftor.
Ranibizumab
Pexidartinib
The excretion of Pitavastatin can be decreased when combined with Pexidartinib.
Ranibizumab
Silibinin
The excretion of Pitavastatin can be decreased when combined with Silibinin.
Ranibizumab
Sacubitril
The excretion of Pitavastatin can be decreased when combined with Sacubitril.
Ranibizumab
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Pitavastatin.
Ranibizumab
Fimasartan
The excretion of Fimasartan can be decreased when combined with Pitavastatin.